Remove 2023-outlook-positive-dental-office-growth
article thumbnail

2023 Outlook: Positive Dental Office Growth

Patient News

As we wade into 2023, the outlook looks very positive for dental office growth. People need dental care, and the pandemic forced governments to acknowledge that dental care is essential. The dental industry is projected to reach incredible growth numbers in the next few years.

article thumbnail

Excellent Business Results and Change in Leadership at the Ivoclar Group

Dentistry Today

per cent higher than in the previous year and therefore above the average market growth rate. He will take some time out from corporate life to explore career options outside the dental industry with particular interest in the world of start-ups. “We The currency-adjusted turnover was 4.9

Marketing 262
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BIOLASE Reports Unaudited Revenue Growth for Full Year 2023 and Provides Outlook for Full Year 2024

Dentistry Today

NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue results for 2023 based on currently available information and expects to report year-over-year growth as it continues to generate interest among dental practitioners for its industry-leading lasers. BIOLASE, Inc. million to $49.2

article thumbnail

3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business

Denticle

3M, which has a huge position in the dental market, is looking at spinning off that portion of their business into a new company. 3M (NYSE: MMM) today announced its intent to spin off its Health Care business, resulting in two world-class public companies well positioned to pursue their respective growth plans.

article thumbnail

Envista Reports Fourth Quarter and Full Year 2023 Earnings

Dentistry Today

Envista Holdings Corporation announced results for the fourth quarter and full year 2023. For the quarter ended December 31, 2023, reported sales were $645.6 Adjusted EBITDA for the fourth quarter of 2023 was $100.5 For the full year 2023, we saw a modest decline in core growth and delivered an adjusted EBITDA margin of 18.1%.